|Michael Eberhardson has a Medical Degree (MD) and a PhD (in Medical Cell Biology) from Uppsala University and is Associate Professor in Gastroenterology at Karolinska Institutet. He is a consultant in Gastroenterology with focus on IBD and medical lead of the Gastro Research Unit at Danderyd Hospital. He also serves part time at the Department of Clinical Immunology, Karolinska University Hospital. Dr Eberhardson has a special interest in immunological monitoring of IBD. He is a member of the board of the Swedish Organisation for the Study of IBD (SOIBD) and a member of the steering committee of the National Quality Registry for Inflammatory Bowel Disease (SWIBREG). He is elected national representative of the European Crohn’s and Colitis Organisation (ECCO).|
|Subrata Ghosh, FRCP, FRCPE, FRCPC, AGAF, FCAHS, is the inaugural director of the Institute of Translational Medicine (ITM), Birmingham and Professor of Translational Medicine, University of Birmingham since June 2016. Prior to this he was the Professor and Chairman of Medicine, University of Calgary, Canada and Head of Medicine, Alberta Health Services, Calgary (2009-2016). He pioneered development of a precision medicine strategy that has now been adopted across Alberta between its three Universities. Between 2002 and 2008 he was the Professor and Chair of gastroenterology at Imperial College London, Hammersmith Hospital and head of interventional medicine division of the Imperial College Hospitals NHS Trust. Prior to this he was consultant gastroenterologist and honorary senior lecturer at University of Edinburgh. He remains adjunct professor of medicine at University of Calgary Canada currently collaborating on precision nutrition and sits on the President’s Visiting Committee of the University of Alberta, Canada.
Subrata Ghosh is a Fellow of the Canadian Academy of Health Sciences and theme lead for Integration cluster of the International Organisation for Study of IBD (IOIBD). He has published over 470 manuscripts in international journals. His h index is currently 86. His research interests are precision medicine in IBD, innovative clinical trials, immune cell plasticity, targeted immunotherapies in IBD, interaction of nutrients and immune system, gut inflammation and nutrition, innate immunity and epidemiology and health care in IBD. He initiated the precision medicine signature project in Alberta Canada. He has been the recipient of multiple individual and large team grants from CIHR, AIHS, MRC, NIHR, Welcome Trust, CCFA, CCUK and CCC, as well as industry partnered research projects. He has served on numerous committees, councils and grant panels regionally, nationally and internationally, and been chief editor, associate editor and editorial board member of a number of international reputable journals.
|Jonas Halfvarson is a Consultant Gastroenterologist specialising in IBD at Örebro University Hospital, Sweden. He graduated as MD at Uppsala University, Sweden, before training in gastroenterology at Örebro University Hospital. He undertook research with Professor Gunnar Järnerot and obtained his PhD, entitled ‘Inflammatory bowel disease in twins; Studies of genetics and environmental factors’ in 2004. Part of his PhD was done at the University of Oxford, UK with Professor Derek Jewell. Today his research focuses on biomarkers in IBD, both from a clinical and from a mechanistic perspective. He has published over 130 peer-reviewed full papers, as well as contributed to several books on IBD. He has served as vice director for the Swedish national PhD and Postdoctoral program for translational gastroenterology and heads the taskforce for genetics and pathophysiology at the Swedish Organisation for the Study of IBD. Today he is appointed Professor at Örebro University and combines his time in clinical practice with his positions at the University. Dr Halfvarson was named a Rising Star in Gastroenterology at the United European Gastroenterology (UEGWeek) in 2011 and is a member of the International Organization for the study of Inflammatory Bowel Disease (IOIBD) since 2014.|
|Linn Inganäs is communications manager at Mag- och tarmförbundet (The Swedish Stomach and Bowel Association). She is also the editor-in-chief, art director and graphic designer for the organisation's membership magazine ”Allt om mage”. Linn Inganäs has a wide range of experience in communications focused on health and the medical/gastroenterological field. She has a bachelor's degree in medical science from Uppsala University and a master’s degree in nutrition from Stockholm University.|
|Susanna Jäghult works as an IBD nurse since many years. She got her PhD in 2012 and her thesis was about "Living with inflammatory disease - HRQOL, worries and stress". She now continues to work both in the clinic and academic world. Susanna is the chair of N-ECCO (the Nurses Committee of ECCO). She was one of the founders of the Swedish Nurse Association (Föreningen för sjuksköterskor inom gastroenterologi i Sverige- FSGS) and was the chair for many years. Susanna is working at the Stockholm Gastro Center, located at Sophiahemmet and is in charge of the work of the the IBD-nurses.|
|Dr Pauliina Molander works as a Senior gastroenterologist at Helsinki University Hospital, Finland. She graduated as MD at Turku University in 1997 and specialized in Internal Medicine in 2003 and Gastroenterology in 2008 at Helsinki University Hospital. Her PhD on Assessment of TNFα blocking therapy in inflammatory bowel disease patients in deep remission was approved in Helsinki University in 2015. Her main research interest in IBD are treatment outcomes and biomarkers. She was a National representative in European Crohn’s and Colitis Organization (ECCO) 2015-2018 and served as a board member and secretary of the Finnish Society of Gastroenterology 2013-2016.|
|Anne Pohju graduated from University of Eastern Finland (Master of Health Science, Nutrition, 2009) and is currently working as a dietitian at Helsinki University Hospital, Finland. Her professional interest lies in home artificial nutrition and nutritional therapy in gastroenterological diseases. Her PhD project focuses on treatment of Finnish adult intestinal failure patients, and she is aiming at defending her thesis early 2022.|
|Joana Torres received her medical degree from the University of Coimbra, Portugal, and completed her fellowship in Gastroenterology in February 2011, at the Hospital Center of Coimbra, Portugal. She is currently working in Hospital Beatriz Ângelo, Loures, Portugal as a Gastroenterology Assistant. She is an active member of the European Crohn´s and Colitis Organization, and a the current chair for ECCO´s guideline committee (GuiCom). She spent three years at Mount Sinai Hospital, NY, working in pre-clinical cohorts, with a focus in populations at risk for developing inflammatory bowel disease, and with a focus in early life microbiome development in IBD, with the goal of better understanding events taking place before disease is diagnosed.|